Redcare Pharmacy NV (ETR:RDC)
Germany · Delayed Price · Currency is EUR 48.60
+0.80 (1.67%)
Jun 3, 2026, 10:05 AM CET
Redcare Pharmacy NV Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Redcare Pharmacy NV stock has a consensus rating of "Buy" and an average price target of €74.28. The average 1-year stock price forecast is 52.84% higher than the current stock price, while the lowest is €40.00 (-17.70%) and the highest is €99.00 (+103.70%).
Price Target: €74.28 (+52.84%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Redcare Pharmacy NV stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Buy Maintains €99.00 | Buy | Maintains | €99.00 | +103.70% | May 13, 2026 |
| Berenberg Bank | Berenberg Bank | Buy Maintains €87.50 | Buy | Maintains | €87.50 | +80.04% | May 7, 2026 |
| Baader Bank | Baader Bank | Buy Maintains €85.00 | Buy | Maintains | €85.00 | +74.90% | May 6, 2026 |
| Barclays | Barclays | Buy Reiterates €60.17 | Buy | Reiterates | €60.17 | +23.80% | May 6, 2026 |
| UBS | UBS | Hold Maintains €53.00 | Hold | Maintains | €53.00 | +9.05% | May 6, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.